Aktien Sensor

Sonova Holding AG has launched its smallest rechargeable in-the-ear hearing aid, Phonak Virto R Infinio, marking a new product launch and potential market expansion.

Straumann Holding AG’s first half results show growth, but also highlight concerns about the company’s ability to sustain its performance in a volatile market.

Abbott Laboratories’ stock price has dipped slightly, but remains strong, with a year-to-date performance and valuation metrics that suggest a moderate level of investment risk.

GE Healthcare adjusts its earnings projections, causing a market reaction.

Coloplast A-S’s stock price has fluctuated in recent days due to broader market trends, but the company’s growth potential in the wound care market remains positive.

McKesson Corp has reported significant growth, with a 23% increase in Q1 revenue and a 341.86% increase in investor returns over the past five years.

Terumo Corp’s stable performance may be a double-edged sword, masking underlying vulnerabilities and a potentially overvalued stock.

Stryker Corporation has announced a quarterly dividend of $0.84 per share, effective August 7.

Abbott Laboratories’ stock price is currently at $131.36 USD, with a 52-week high of $141.23 and a low of $107.71, and valuation metrics including a price-to-earnings ratio of 19.6993 and a price-to-book ratio of 4.52144.

Coloplast A-S’s stock is declining, but the company’s wound care segment is poised for growth due to a projected 6.5% CAGR in the global wound care market from 2025 to 2030.